<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35505407</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1824-7288</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>48</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Italian journal of pediatrics</Title>
          <ISOAbbreviation>Ital J Pediatr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia.</ArticleTitle>
        <Pagination>
          <StartPage>64</StartPage>
          <MedlinePgn>64</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">64</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13052-022-01254-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In recent years, reports of refractory Mycoplasma pneumoniae pneumonia (RMPP) have gradually increased, including reports on how these conditions threaten the lives of children. However, the specific mechanism of Mycoplasma pneumoniae pneumonia (MPP) remains unclear. This study aimed to investigate the relationship between community-acquired respiratory distress syndrome toxin (CARDS TX) and High-mobility group box protein 1-Toll-like receptors-Myeloid differentiation factor 88 (HMGB1-TLRs-MyD88) in MPP and to examine the immune pathogenesis of Mycoplasma pneumoniae infection.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Children who were diagnosed with MPP and examined by bronchoscopy were included in the MPP group. Additionally, children who underwent bronchoscopy because of bronchial foreign bodies in the same period were included in the control group. Gene expression of CARDS TX, HMGB1, Toll-like receptor 2 (TLR2), Toll-like receptor 4 (TLR4), MyD88, and cluster of differentiation 14 (CD14) in bronchoalveolar lavage fluid (BALF) were detected using real-time reverse transcription-polymerase chain reaction. Correlations between CARDS TX and HMGB1-TLRs-MyD88 were analyzed.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">CARDS TX, HMGB1, TLR2, MyD88, and CD14 mRNA expression in BALF in the MPP group was significantly higher than that in the control group (all P &lt; 0.05). CARDS TX mRNA expression was positively correlated with HMGB1, TLR2, MyD88, and CD14 mRNA expression (all P &lt; 0.05). Furthermore, HMGB1 mRNA expression was positively correlated with TLR2, MyD88, and CD14 mRNA expression (all P &lt; 0.05).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CARDS TX may participate in the immune pathogenesis of MPP through the HMGB1-TLRs/CD14-MyD88 pathway.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Fan</LastName>
            <ForeName>Yujie</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Ding</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yuqin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Dandan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Wei-Fang</ForeName>
            <Initials>WF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China. zwf_1969@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kong</LastName>
            <ForeName>Xiaoxing</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Children's Hospital of Soochow University, Soochow University, Suzhou, 215003, China. kongxiaoxingshi@sina.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ital J Pediatr</MedlineTA>
        <NlmUniqueID>101510759</NlmUniqueID>
        <ISSNLinking>1720-8424</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051195">Toll-Like Receptor 2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053594" MajorTopicYN="N">Myeloid Differentiation Factor 88</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051195" MajorTopicYN="N">Toll-Like Receptor 2</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cluster of differentiation 14</Keyword>
        <Keyword MajorTopicYN="N">Community-acquired respiratory distress syndrome toxin</Keyword>
        <Keyword MajorTopicYN="N">High-mobility group box protein 1</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae pneumonia</Keyword>
        <Keyword MajorTopicYN="N">Toll-like receptor 2</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>23</Hour>
          <Minute>50</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35505407</ArticleId>
        <ArticleId IdType="pmc">PMC9066890</ArticleId>
        <ArticleId IdType="doi">10.1186/s13052-022-01254-1</ArticleId>
        <ArticleId IdType="pii">10.1186/s13052-022-01254-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Atkinson TP, Waites KB. Mycoplasma pneumoniae Infections in Childhood[J] Pediatr Infect Dis J. 2014;33(1):92–94. doi: 10.1097/INF.0000000000000171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000000171</ArticleId>
            <ArticleId IdType="pubmed">24346598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao LW, Yin J, Hu YH, et al.  The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016[J] EPIDEMIOLOGY AND INFECTION. 2019;147:e192. doi: 10.1017/S0950268819000839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268819000839</ArticleId>
            <ArticleId IdType="pmc">PMC6518602</ArticleId>
            <ArticleId IdType="pubmed">31364532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens[J] Proc Natl Acad Sci U S A. 2006;103(17):6724–6729. doi: 10.1073/pnas.0510644103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0510644103</ArticleId>
            <ArticleId IdType="pmc">PMC1458948</ArticleId>
            <ArticleId IdType="pubmed">16617115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding Y, Chu C, Li Y, et al.  High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia[J] BMC Infect Dis. 2018;18(1):439. doi: 10.1186/s12879-018-3346-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-018-3346-8</ArticleId>
            <ArticleId IdType="pmc">PMC6116361</ArticleId>
            <ArticleId IdType="pubmed">30157804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Health Commission of the People’s Republic of China. National Administration of Traditional Chinese Medicine  Guideline for diagnosis and treatment of community-acquired pneumonia in Children (2019 version)[J] Chin J Clin Infect Dis. 2019;12(1):6–13.</Citation>
        </Reference>
        <Reference>
          <Citation>Experts Group of Pediatric Respiratory Endoscopy. Talent Exchange Service Centerof National Health Commissio. Endoscopy Committee et al.  Guideline of pediatric flexible bronchoscopy in China (2018 version)[J] Chin J Appl Clin Pediatr. 2018;33(13):983–989.</Citation>
        </Reference>
        <Reference>
          <Citation>Yan Y, Wei Y, Jiang W, Hao C. The clinical characteristics of corticosteroid-resistant refractory Mycoplasma pneumoniae pneumonia in children[J] Sci Rep. 2016;6:39929. doi: 10.1038/srep39929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep39929</ArticleId>
            <ArticleId IdType="pmc">PMC5180238</ArticleId>
            <ArticleId IdType="pubmed">28008989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SJ, Pai KS, Kim AR, et al.  Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae Infection[J] Allergy Asthma Immunol Res. 2012;4(1):55–57. doi: 10.4168/aair.2012.4.1.55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4168/aair.2012.4.1.55</ArticleId>
            <ArticleId IdType="pmc">PMC3242064</ArticleId>
            <ArticleId IdType="pubmed">22211173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q. Mechanism and Treatment of Refractory Mycoplasma Pneumoniae Pneumonia in Children [J] J Pediatr Pharm. 2019;25(6):61–63.</Citation>
        </Reference>
        <Reference>
          <Citation>Maselli DJ, Medina JL, Brooks EG, et al.  The immunopathologic effects of mycoplasma pneumoniae and community-acquired respiratory distress syndrome toxin. a primate model[J] Am J Respir Cell Mol Biol. 2018;58(2):253–260. doi: 10.1165/rcmb.2017-0006OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2017-0006OC</ArticleId>
            <ArticleId IdType="pmc">PMC5805996</ArticleId>
            <ArticleId IdType="pubmed">28915064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li G, Fan L, Wang Y, et al.  High co-expression of TNF-alpha and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia[J] Mol Med. 2019;25(1):38. doi: 10.1186/s10020-019-0105-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s10020-019-0105-2</ArticleId>
            <ArticleId IdType="pmc">PMC6688229</ArticleId>
            <ArticleId IdType="pubmed">31399022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimizu T, Kida Y, Kuwano K. Cytoadherence-dependent induction of inflammatory responses by Mycoplasma pneumoniae[J] Immunology. 2011;133(1):51–61. doi: 10.1111/j.1365-2567.2011.03408.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2567.2011.03408.x</ArticleId>
            <ArticleId IdType="pmc">PMC3088967</ArticleId>
            <ArticleId IdType="pubmed">21320122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson U, Wang H, Palmblad K, et al.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes[J] J Exp Med. 2000;192(4):565–570. doi: 10.1084/jem.192.4.565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.192.4.565</ArticleId>
            <ArticleId IdType="pmc">PMC2193240</ArticleId>
            <ArticleId IdType="pubmed">10952726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang R, Chen R, Zhang Q, et al.  HMGB1 in health and disease[J] Mol Aspects Med. 2014;40:1–116. doi: 10.1016/j.mam.2014.05.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2014.05.001</ArticleId>
            <ArticleId IdType="pmc">PMC4254084</ArticleId>
            <ArticleId IdType="pubmed">25010388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Afkham A, Eghbal-Fard S, Heydarlou H, et al.  Toll-like receptors signaling network in pre-eclampsia: An updated review[J] J Cell Physiol. 2019;234(3):2229–2240. doi: 10.1002/jcp.27189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.27189</ArticleId>
            <ArticleId IdType="pubmed">30221394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai JF, Zindl CL, Duffy LB, et al.  Critical role of macrophages and their activation via MyD88-NFkappaB signaling in lung innate immunity to Mycoplasma pneumoniae[J] PLoS One. 2010;5(12):e14417. doi: 10.1371/journal.pone.0014417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0014417</ArticleId>
            <ArticleId IdType="pmc">PMC3009709</ArticleId>
            <ArticleId IdType="pubmed">21203444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by Toll-like receptors[J] J Endotoxin Res. 2002;8(6):459–463. doi: 10.1177/09680519020080060101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/09680519020080060101</ArticleId>
            <ArticleId IdType="pubmed">12697090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manukyan M, Triantafilou K, Triantafilou M, et al.  Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1[J] Eur J Immunol. 2005;35(3):911–921. doi: 10.1002/eji.200425336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.200425336</ArticleId>
            <ArticleId IdType="pubmed">15714590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakata T, Yasuda M, Fujita M, et al.  CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex[J] Cell Microbiol. 2006;8(12):1899–1909. doi: 10.1111/j.1462-5822.2006.00756.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2006.00756.x</ArticleId>
            <ArticleId IdType="pubmed">16848791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He J, You X, Zeng Y, et al.  Mycoplasma genitalium-derived lipid-associated membrane proteins activate NF-kappaB through toll-like receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway[J] Clin Vaccine Immunol. 2009;16(12):1750–1757. doi: 10.1128/CVI.00281-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00281-09</ArticleId>
            <ArticleId IdType="pmc">PMC2786392</ArticleId>
            <ArticleId IdType="pubmed">19793902</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
